a2zShowOEC - 2697
Tweet
Sessions
Speakers
Exhibitors
Products
Press Releases
Show Specials
Floor Plan
Buzz
AMGEN
Profile
Products
Press Releases
Show Specials
Details
Amgen Opens Nomination Process For LabCentral Residency
Amgen Announces Top-Line Results From Phase 3 KYPROLIS® (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients
Amgen Announces Erenumab Significantly Reduces Monthly Migraine Days In Patients With Episodic Migraine In First Phase 3 Study
Profile
Products
Press Releases
Show Specials
Home
Sessions
Speakers
Exhibitors
Products
Press Releases
Show Specials
Floor Plan
Tweet
Login
|
Back to top
ChirpE